What is the most important outcome parameter in ankylosing spondylitis

被引：13

作者：

Braun, J. ^{[1
,2
]}

Sieper, J. ^{[3
]}

机构：

[1] Rheumazentrum Ruhrgebiet, D-44652 Herne, Germany

[2] Ruhr Univ Bochum, Bochum, Germany

[3] Univ Berlin, Charite Univ Med, Dept Gastroenterol & Rheumatol, Berlin, Germany

来源：

RHEUMATOLOGY | 2008年 / 47卷 / 12期

关键词：

D O I：

10.1093/rheumatology/ken357

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1738 / 1740

页数：3

共 57 条

[1]

Anderson JJ, 2001, ARTHRITIS RHEUM-US, V44, P1876, DOI 10.1002/1529-0131(200108)44:8<1876::AID-ART326>3.0.CO

[2]

2-F

[3]

[Anonymous], 2004, Cochrane Database Syst Rev, DOI DOI 10.1002/14651858.CD001160.PUB2

[4] Radiographic progression in patients with ankylosing spondylitis after 4 yrs of treatment with the anti-TNF-α antibody infliximab [J].

Baraliakos, X. ;

Listing, J. ;

Brandt, J. ;

Haibel, H. ;

Rudwaleit, M. ;

Sieper, J. ;

Braun, J. .

RHEUMATOLOGY, 2007, 46 (09) :1450-1453

[5] Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes [J].

Baraliakos, X. ;

Listing, J. ;

Rudwaleit, M. ;

Haibel, H. ;

Brandt, J. ;

Sieper, J. ;

Braun, J. .

ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (07) :910-915

[6] Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept:: Clinical and magnetic resonance imaging data [J].

Baraliakos, X ;

Brandt, J ;

Listing, J ;

Haibel, H ;

Sörensen, H ;

Rudwaleit, M ;

Sieper, J ;

Braun, J .

ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2005, 53 (06) :856-863

[7] Inflammation in ankylosing spondylitis:: a systematic description of the extent and frequency of acute spinal changes using magnetic resonance imaging [J].

Baraliakos, X ;

Landewé, R ;

Hermann, KG ;

Listing, J ;

Golder, W ;

Brandt, J ;

Rudwaleit, M ;

Bollow, M ;

Sieper, J ;

van der Heijde, D ;

Braun, J .

ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (05) :730-734

[8]

BARALIAKOS X, 2008, ANN RHEUM DIS

[9] The unmet need for anti-tumour necrosis factor (anti-TNF) therapy in ankylosing spondylitis [J].

Barkham, N ;

Kong, KO ;

Tennant, A ;

Fraser, A ;

Hensor, E ;

Keenan, AM ;

Emery, P .

RHEUMATOLOGY, 2005, 44 (10) :1277-1281

[10] Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis [J].

Brandt, J ;

Khariouzov, A ;

Listing, J ;

Haibel, H ;

Sörensen, H ;

Grassnickel, L ;

Rudwaleit, M ;

Sieper, J ;

Braun, J .

ARTHRITIS AND RHEUMATISM, 2003, 48 (06) :1667-1675

← 1 2 3 4 5 6 →